XML 34 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Common Stock and Stockholders' Equity (Deficit)
12 Months Ended
Jan. 31, 2018
Equity [Abstract]  
Common Stock and Stockholders' Equity (Deficit)
Common Stock and Stockholders' Equity (Deficit)
Redeemable Convertible Preferred Stock
Immediately prior to the completion of the IPO in April 2017, all shares of redeemable convertible preferred stock then outstanding were converted into 59,491,640 shares of common stock on a one-to-one basis and then immediately reclassified into Class B common stock and additional paid-in capital. As of January 31, 2018, there were no shares of redeemable convertible preferred stock issued and outstanding.
The authorized, issued and outstanding shares of redeemable convertible preferred stock (Preferred Stock) and liquidation preferences as of January 31, 2017 were as follows:  
Series 
Authorized
Shares  
 
Issued and
Outstanding
Shares
 
Liquidation
Preference
 
Carrying
Value
Series A
14,210,789

 
14,210,783

 
$
11,373,000

 
$
11,322,000

Series B
12,015,123

 
11,986,055

 
16,500,000

 
16,420,000

Series C
10,708,782

 
10,708,780

 
25,000,000

 
24,872,000

Series D
6,833,654

 
6,833,651

 
27,500,000

 
27,416,000

Series E
9,484,234

 
9,484,234

 
75,000,000

 
74,500,000

Series F
6,242,000

 
6,241,936

 
75,000,000

 
73,424,000

 
59,494,582

 
59,465,439

 
$
230,373,000

 
$
227,954,000

 
 
 
 
 
 
 
 

Series B Redeemable Convertible Preferred Stock Warrant
As of January 31, 2017, there was an outstanding warrant to purchase 29,058 shares of Series B redeemable convertible Preferred Stock at $1.38 per share (Series B warrant). The fair value of the Series B warrant was $0.3 million as of January 31, 2017. The Series B warrant was net exercised at the IPO price immediately following the completion of the Company's IPO in April 2017, and was reclassified to additional paid-in capital.
Common Stock
Immediately prior to the completion of the IPO, all shares of common stock then outstanding were reclassified into Class B common stock. Shares offered and sold in the IPO consisted of the newly authorized shares of Class A common stock.
As of January 31, 2018, the Company had authorized 1,000,000,000 shares of Class A common stock and had authorized 120,000,000 shares of Class B common stock, each with par value $0.0001 per share. As of January 31, 2017, the Company had authorized 120,000,000 shares of common stock with par value $0.0001 per share. As of January 31, 201870,609,898 shares of Class A common stock and 33,361,106 shares of Class B common stock were issued and outstanding. Holders of Class A and Class B common stock are entitled to one vote per share and 10 votes per share, respectively, and the shares of Class A common stock and Class B common stock are identical, except for voting and conversion rights. Shares of Class B common stock may be converted into Class A common stock at any time at the option of the stockholder on a one-for-one basis, and are automatically converted into Class A common stock upon sale or transfer, subject to certain limited exceptions. Shares of Class A common stock are not convertible.
As of January 31, 2018, shares of common stock reserved for future issuance are as follows:
 
 
Options and unvested RSUs outstanding
27,779,974

Available for future stock option and RSU grants
9,842,925

Available for ESPP
2,430,627

 
40,053,526

 
 

Awards Issued as Charitable Contributions
During the year ended January 31, 2018, the Company issued 24,287 shares of Class A common stock as charitable contributions and recognized $0.7 million as general and administrative expense in the consolidated statement of operations. During the years ended January 31, 2017 and 2016, the Company issued 13,935 and 17,433 shares, respectively, of Class B common stock as charitable contributions and recognized $0.1 million for both respective periods as general and administrative expense in the consolidated statement of operations.